October 22, 2019
Mountain View, California-based Beddr is taking aim at the employer market. The sleep health company announced this morning the launch of a new program that provides employees with a sleep tracking device, weekly coaching and referrals to experts.
“Beddr’s program helps people who have a combination of physiological, psychological and lifestyle causes of their chronic sleep issues,” Michael Kisch...
October 10, 2019
Sentio, a behavioral health startup offering an emotion-sensing wearable and a connected support app, has raised $4.5 million in seed funding. The round was led by Felicis Ventures, with additional support from Anthemis Exponential Ventures and SOSV, and brings the company’s total raise to $6.3 million.
WHAT THEY DO
Sentio’s Feel platform is headlined by the Feel Emotion Sensor, a wristband that...
September 12, 2019
Like a swimmer emerging from an impossibly long dive, swimming wearable maker Instabeat has resurfaced after a long, self-imposed stealth period.
Long-term industry insiders might remember the Beirut, Lebanon, company (now partly based in San Francisco) that raised more than $50,000 on Indiegogo back in 2013 for a heart rate tracker and heads-up display that attaches to a swimmer’s goggles,...
September 10, 2019
Sleep tech company Dreem launched the second version of its AI-enabled sleep tracking headband and companion app, Dreem 2, in the U.S. today.
The technology includes an EEG, heart rate, respiration and movement tracker. A user’s information is then monitored and analyzed by the system for their review the next day. The headband has a companion app where the customers’ sleep data can be...
July 30, 2019
A new patent filing suggests that Microsoft, which seemed to have definitively abandoned health wearables with the shutdown of the Microsoft Band in 2016 (and the decommissioning of its corresponding software program earlier this year) may be at least thinking about getting back in the game.
The patent filing, first spotted by Neowin, is for what the writers call a "multidimensional optical...
May 23, 2019
Amazon is building a wrist-worn device and accompanying app that listens to the wearer’s voice to identify their emotions, according to an anonymous source as well as internal documents acquired and reported on by Bloomberg.
The system, codenamed Dylan, is intended to be used as a health and wellness product, and might be adapted to provide the wearer guidance on how they may more effectively...
March 4, 2019
Microsoft announced that come the end of May it is shutting down its Health Dashboard and offering refunds to Microsoft Band users. This news comes two and a half years after the tech giant discontinued its fitness tracker offering.
Until the end of May, users will be able to transfer their data using a Microsoft export tool; after that, all the data will be deleted. Existing Bands will still...
Verisense by Shimmer IMU (Photo courtesy Shimmer)
February 19, 2019
Shimmer, a Dublin-based wearable sensor company, has launched a new sensor platform for clinical trials called VeriSense. At launch, the platform will work with Shimmer's IMU, or inertial measurement unit, sensor, which can measure activity and sleep from the wrist, as well as network with sensors elsewhere on the body to monitor musculoskeletal and neurological conditions.
The company has been...
February 6, 2019
Edinburgh-headquartered Current Health, formerly known as snap40, has received FDA Class II clearance for its remote patient monitoring solution, the Scottish start-up announced today.
Current's AI-enabled wearable monitors vital signs with “ICU-level accuracy”, according to the start-up, and proprietary algorithms analyse data to offer insights into a patient’s health, alerting staff in case...
November 14, 2018
De Novo clearance for urinary incontinence wearable. The FDA has granted De Novo clearance to Atlantic Therapeutics’ Innovo therapy device, an externally worn electrical muscle stimulator for the treatment of stress urinary incontinence. The wearable is intended for adult women as a front-line or second-line therapy, and in a multi-center randomized controlled trial recorded an 87 percent rate of...